share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Mar 20 06:47
Summary by Moomoo AI
無錫藥明康德新藥開發股份有限公司（药明康德）於2024年3月8日至3月20日期間進行了多次股份回購，並於3月20日註銷了部分股份。根據於香港聯合交易所有限公司證券上市規則披露，公司在上述日期內共回購了2,789,826股A股普通股，佔公司發行前總股本的約0.11%。此外，公司亦於3月20日註銷了之前回購的20,275,407股A股。經過這些變動後，公司於3月20日的結存為2,546,175,758股。股份回購的價格範圍從RMB 50.41至RMB 57.32，而回購的股份在市場上的價格則介於RMB 50.02至RMB 57.2之間。公司董事會已正式授權並批准了每項證券發行，並確認已收取全部款項，履行了所有上市先決條件，並遵守了所有相關法律規定。
無錫藥明康德新藥開發股份有限公司（药明康德）於2024年3月8日至3月20日期間進行了多次股份回購，並於3月20日註銷了部分股份。根據於香港聯合交易所有限公司證券上市規則披露，公司在上述日期內共回購了2,789,826股A股普通股，佔公司發行前總股本的約0.11%。此外，公司亦於3月20日註銷了之前回購的20,275,407股A股。經過這些變動後，公司於3月20日的結存為2,546,175,758股。股份回購的價格範圍從RMB 50.41至RMB 57.32，而回購的股份在市場上的價格則介於RMB 50.02至RMB 57.2之間。公司董事會已正式授權並批准了每項證券發行，並確認已收取全部款項，履行了所有上市先決條件，並遵守了所有相關法律規定。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. (Pharmaceutical Ming Kand) made several share repurchases between March 8 and March 20, 2024, and delisted some shares on March 20. Pursuant to the disclosure of the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company repurchased a total of 2,789,826 shares of Class A common stock during the above date, representing approximately 0.11% of the Company's total share capital prior to issue. In addition, on March 20, the Company wrote down 20,275,407 shares of A shares previously repurchased. Following these changes, the company had a deposit of 2,546,175,758 shares as of March 20. The share repurchase price ranges from RMB 50.41 to RMB 57.32, while the repurchased shares range from RMB 50.02 to RMB 57.2 on the market. The Board of Directors has formally authorized and approved each issuance of securities and confirms that all monies have been received, that all listing prerequisites have been met, and that all relevant legal requirements have been complied with.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. (Pharmaceutical Ming Kand) made several share repurchases between March 8 and March 20, 2024, and delisted some shares on March 20. Pursuant to the disclosure of the Listing Rules of the Stock Exchange of Hong Kong Limited, the Company repurchased a total of 2,789,826 shares of Class A common stock during the above date, representing approximately 0.11% of the Company's total share capital prior to issue. In addition, on March 20, the Company wrote down 20,275,407 shares of A shares previously repurchased. Following these changes, the company had a deposit of 2,546,175,758 shares as of March 20. The share repurchase price ranges from RMB 50.41 to RMB 57.32, while the repurchased shares range from RMB 50.02 to RMB 57.2 on the market. The Board of Directors has formally authorized and approved each issuance of securities and confirms that all monies have been received, that all listing prerequisites have been met, and that all relevant legal requirements have been complied with.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more